Lecture 15C Reproductive system concerns Flashcards
Amenorrhea
Absence of menstrual flow
Not a disease, often the sign of one
Most common and benign → result of pregnancy
May be clinical symptom of a variety of disorders
First action w/ a pt. reporting amenorrhea is a pregnancy test (hCG); if negative, usually a sign of clinical disorder. Dylantin and COCs associated with amenorrhea.
Exercise-associated amenorrhea
Female athlete triad: 1. Eating disorder; 2. amenorrhea; 3. premature osteoporosis.
Nutritional considerations for amenorrhea
Daily calcium intake 1000-1500 mg
Vitamin D 400-600 IU
Primary dysmenorrhea
Abnormally increased uterine activity/myometrial contractions
Result of prostaglandins in 2nd half of cycle - these women will have more intense labors.
Most common in late teens and early twenties, incidence declines w/age
Primary dysmenorrhea management
Decrease salt and refined sugar intake 7-10 d before menses, natural diuretics.
NSAIDs - ibuprofen taken at regular intervals
Secondary dysmenorrhea
Acquired menstrual pain
Menstrual pain that develops later in life than primary (after age 25)
May have other symptoms suggestive of underlying cause
Dull, lower abdominal aching, radiating to back or thighs
Bloating or pelvic fullness
Hypogonadotropic amenorrhea
Suppression of the hypothalamus, from stress, etc.
PMS/PMDD with partial hysterectomy
PMS and PMDD can still occur because ovarian function is necessary for the disorder, not the presence of a uterus.
Nutritional supplementation with PMS/PMDD
Vitamin B6, up to 100-150 mg/day Vitamin E, up to 600 IU/day Calcium, 1000 -1200 mg/day Magnesium, up to 300-400 mg /day Evening Primrose Oil (*not* during pregnancy)
PMDD pharmacological therapy
SSRIs: Fluoxetine (Sarafem); Paroxetine (Paxil); Sertaline (Zoloft)
YAZ (an oral contraceptive)
Endometriosis
Presence and growth of endometrial tissue outside of the uterus. Believed to be the result of reverse flow of blood and endometrial tissue.
Tissue found most commonly in and near ovaries; can be in stomach, lungs, spleen, and intestines. Often grows on surgical scars (i.e., previous cervical surgery.
Disappears with menopause
A leading cause of infertility
Endometriosis and menstruation
Each month, estrogen causes all endometrial tissue, regardless of location, to become inflamed and painful - pelvic pain, sacral backache, dyspareunia, secondary dysmenorrhea, constipation and pain during exercise.
Average age of menopause
51-52
Average of perimenopause or climacteric phase
46
Declaration of menopause requires
No menstrual periods (no ovulation) for 12 months, including spotting - continue to use contraception.
Hormonal changes in menopause
- FSH is elevated because the ovarian follicle becomes less sensitive to it.
- Progesterone and estrogen is decreased.
SCOVU mnemonic for menopause symptoms
S - Sleep disorders C - Cardiovascular O - Osteoporosis V - Vasomotor U - Urogenital (Also: Cognitive disorders)
Due to falling estrogen levels, there is an increased risk of developing _ after menopause
Cardiovascular disease: Causes an increase in LDL (bad cholesterol) and a decrease in HDL (good cholesterol); causes decreased elasticity of the blood vessels.
Osteoporosis and menopause
Estrogen plays a role in stimulating osteoblasts, as well as the conversion of vitamin D to calcitonin; falling estrogen levels inhibit new bone from being formed - results in thinning of the bones.
Depoprovera
Causes reversible osteoporosis, women should not take this medication for more than 2 years.
Increased intake of calcium and vitamin D
At age 40 - at least 1200 mg/day of calcium and at least 400 IU/day of vitamin D.
Medications for osteoporosis
Miacalcin, Fosamax, Actonel, Boniva, Reclast, Evista - follow instructions precisely - some require woman to remain in an upright position afterward.
Menopause hormonal therapy (MHT)
Controversial - long term use is associated with increased risk for blood clots, heart attack, stroke, invasive breast cancer; should only be used on a short term basis (1-3 years) and for very disruptive menopausal symptoms.
Contraindications to hormone therapy
Women w/increased risk of cardiovascular disease
High risk or hx of breast CA
May worsen myomas of the uterus
Women with a known hx of gallbladder disease (conjugated estrogens are associated with an increased incidence)